Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disease exacerbation after rituximab induction in neuromyelitis optica.
A study of experimental autoimmune encephalomyelitis in dogs; as a disease model for canine necrotizing encephalitis.
Examining vascular remodeling in the hypoxic central nervous system.
Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System.
Potential pathogens in multiple sclerosis (MS.
Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study.
Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues.
Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barré Syndrome.
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.
Microglia Plasticity During Health and Disease: An Immunological Perspective.
Pain in acquired inflammatory demyelinating polyneuropathies.
Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).
Width of 3. Ventricle: reference values and clinical relevance in a cohort of patients with relapsing remitting multiple sclerosis.
Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.
[Anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
Optic neuritis as first clinical manifestations the multiple sclerosis.
Gene Therapy for Rare Central Nervous System Diseases Comes to Age.
Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders.
Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis.
Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Chronic Severe Hyponatremia and Cardiopulmonary Bypass: Avoiding Osmotic Demyelination Syndrome.
Glial influences on BBB functions and molecular players in immune cell trafficking.
Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.
Comparison of ActiGraph activity monitors in persons with multiple sclerosis and controls.
B Cells Fuel Inflammation in Multiple Sclerosis.
Pages
« first
‹ previous
…
622
623
624
625
626
627
628
629
630
…
next ›
last »